Capmatinib is a pill for treating advanced non-small cell lung cancer in people who have a specific gene change. It’s like a lock for a special protein called MET kinase that helps slow down tumor growth. You can get this medicine in two doses—150 mg and 200 mg—they’re all tablets with a coating.
The usual dose is 400 mg, taken two times a day, and it doesn’t matter if you eat before. It comes in bottles with 60 pills in each.
